[25-014694] nhlbi DIR requires the purchase of 20 infinium methylation screening array-48 kits in order to support project that has important translational, mechanistic, and public health implications…
Ended Awarded Last action
- Contract number
- 75N92025F00021
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $105,235
Award facts
- Contract value 100% obligated
- $105,235.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92122, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $105,235 |
About this award
This federal contract award to Illumina, Inc. is a $105,235.20 Firm Fixed Price Delivery Order issued by the National Heart Lung and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH). The award is for the purchase of 20 Infinium Methylation Screening Array-48 Kits to support a project with important translational, mechanistic, and public health implications for cardiovascular outcomes in the American population. The ultimate completion date for this contract is January 31, 2026. This award does not utilize a set-aside designation. Illumina, Inc. is a for-profit biotechnology company that specializes in genetic sequencing and genomic analysis technologies. The company has been awarded multiple federal contracts and Indefinite Delivery Vehicles from agencies such as the USDA, VA, and other civilian and defense agencies, highlighting its role as a key technology provider for scientific and diagnostic research initiatives across the government.
Description
[25-014694] nhlbi DIR requires the purchase of 20 infinium methylation screening array-48 kits in order to support project that has important translational, mechanistic, and public health implications for cardiovascular outcomes in american populatio
Quick answers
Who was awarded contract 75N92025F00021?
75N92025F00021 was awarded to Illumina, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on August 20, 2025.
How much is contract 75N92025F00021 worth?
The government has obligated $105,235 on 75N92025F00021.
Is contract 75N92025F00021 an order under another contract?
Yes. 75N92025F00021 is a delivery order under 75N92020D00022, an indefinite delivery contract.
Was contract 75N92025F00021 competed?
The extent of competition for 75N92025F00021 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award